Pfizer Europe Ma Eeig
SpainAll drugs from this manufacturer
-
It is a vaccine designed to prevent lung disease caused by respiratory syncytial virus (RSV). It is used to protect infants (from birth to 6 months) when administered to pregnant women, and also for individuals aged 18 years or older.
Dosage form: powder and solvent for solution for injection
-
It is used for the treatment and prevention of bleeding in patients with hemophilia B (congenital factor IX deficiency) of all ages, helping the blood to clot.
Dosage form: powder and solvent for solution for injection
Active substance Dosage nonacog alfa 1000 UI -
It is used for the treatment and prevention of bleeding in patients with hemophilia B (congenital factor IX deficiency) in all age groups.
Dosage form: powder and solvent for solution for injection
Active substance Dosage nonacog alfa 2000 UI -
It is used for the treatment and prevention of bleeding in patients with hemophilia B (congenital factor IX deficiency) of all ages.
Dosage form: powder and solvent for solution for injection
Active substance Dosage nonacog alfa 250 UI -
It is used for the treatment and prevention of bleeding in patients with hemophilia B (congenital factor IX deficiency) of all ages.
Dosage form: powder and solvent for solution for injection
Active substance Dosage nonacog alfa 3000 UI -
What is BeneFIX used for?": "It is used for the treatment and prevention of bleeding in patients with hemophilia B (congenital factor IX deficiency) of all ages.", "When should I not use BeneFIX?": "It must not be used if you are allergic to nonacog alfa, to any of its components, or if you are allergic to hamster proteins.", "How should the medication be administered?": "It is administered via intravenous (IV) infusion after mixing the powder with the included solvent. You must follow the administration instructions provided by your doctor exactly.", "What side effects can BeneFIX cause?": "It may cause very frequent side effects such as headache, cough, or fever. Other common effects include dizziness, nausea, vomiting, skin rashes, or reactions at the injection site. Severe allergic reactions, development of inhibitors (antibodies that reduce the efficacy of the treatment), or risk of blood clots (thrombosis) may also occur.", "What should I do if I have an allergic reaction?": "If you experience signs of a severe allergic reaction (such as difficulty breathing, swelling of the face or throat, or low blood pressure), you must stop the infusion immediately and seek emergency medical help.", "Can I take other medications while using this treatment?": "You must inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medication.", "What precautions should I take regarding the dose?": "The dose is decided by your doctor based on your individual needs. If you inject an amount greater than the recommended dose or if the bleeding does not stop as expected, you must contact your doctor immediately."
Dosage form: powder and solvent for solution for injection
Active substance Dosage nonacog alfa 500 UI -
It is used to treat adults with acute lymphoblastic leukemia, a type of blood cancer characterized by an excess of white blood cells, specifically in patients who have already tried other treatments without success.
Dosage form: powder for concentrate for solution for infusion
Active substance Dosage inotuzumab ozogamicin 1 mg -
Dosage form: tablets, film-coated
Active substance Dosage bosutinib monohydrate 100 mg -
It is used to treat adults and children aged 6 years and older with a type of leukemia called Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML), either newly diagnosed in the chronic phase, or in cases where other medications have not worked or are not suitable. It is also used in adults with Ph+ CML in the accelerated or blast phase when previous treatments have not been effective.
Dosage form: capsules, hard
Active substance Dosage bosutinib monohydrate 103,40 mg -
It is used to treat adults and children aged 6 years and older with a type of leukemia called Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML), either in newly diagnosed chronic phase or in accelerated or blast phase when other medicines have not worked or are not suitable.
Dosage form: tablets, film-coated
Active substance Dosage bosutinib monohydrate 413,6 mg -
It is used to treat adults and children aged 6 years and older with a type of leukemia called Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML), either in newly diagnosed chronic phase or in accelerated or blast phase, for whom other medicines have not been effective or are not suitable.
Dosage form: capsules, hard
Active substance Dosage bosutinib monohydrate 51,70 mg -
It is used to treat adults and children aged 6 years and older with a type of leukemia called Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in newly diagnosed chronic phase, or for those for whom other medicines have not worked or are not suitable. It is also used in adults with Ph+ CML in accelerated phase or blast phase when other treatments have not been effective.
Dosage form: tablets, film-coated
Active substance Dosage bosutinib monohydrate 500 mg -
It is used in adults to help them stop smoking by helping to relieve anxiety and withdrawal symptoms. It may also reduce the pleasure derived from cigarettes if smoking occurs during treatment.
Dosage form: tablets, film-coated
Active substance Dosage varenicline 0,5 mg -
It is used in adults to help them stop smoking, as it can relieve the anxiety and withdrawal symptoms associated with this process, as well as reduce the pleasure derived from cigarettes if smoking occurs during treatment.
Dosage form: tablets, film-coated
Active substance Dosage varenicline 0,5 mg -
It is used in adults to help them stop smoking by helping to relieve anxiety and withdrawal symptoms, and by reducing the pleasure derived from cigarettes if smoking occurs during treatment.
Dosage form: tablets, film-coated
Active substance Dosage varenicline 1 mg -
It is used to treat adults and adolescents aged 12 years and older with moderate to severe atopic dermatitis (atopic eczema), helping to reduce skin itching and inflammation.
Dosage form: tablets, film-coated
Active substance Dosage abrocitinib 100 mg -
It is used to treat adults and adolescents aged 12 years and older with moderate to severe atopic dermatitis (atopic eczema), helping to reduce itching and skin inflammation.
Dosage form: tablets, film-coated
Active substance Dosage abrocitinib 200 mg -
It is used to treat adults and adolescents aged 12 years and older with moderate to severe atopic dermatitis (atopic eczema), helping to reduce skin itching and inflammation.
Dosage form: tablets, film-coated
Active substance Dosage abrocitinib 50 mg -
It is used to treat osteoporosis in postmenopausal women who are at an increased risk of fractures, helping to slow down bone thinning.
Dosage form: tablets, film-coated
Active substance Dosage bazedoxifeno acetato 20 mg -
It is used to relieve menopausal symptoms, such as hot flashes (heat in the face, neck, and chest), in postmenopausal women who still have a uterus and who have not had their period in the last 12 months.
Dosage form: tablets, modified release
Active substance Dosage conjugated estrogens 0,45 mg bazedoxifeno acetato 20 mg -
It is used for the short-term treatment of pain in adults following surgery.
Dosage form: powder and solvent for solution for injection
Active substance Dosage parecoxib 40 mg -
It is used for the short-term treatment of pain in adults following surgery.
Dosage form: powder for solution for injection
Active substance Dosage parecoxib 40 mg -
It is used to treat invasive candidiasis, a serious fungal infection in the blood or other internal organs caused by yeasts called Candida.
Dosage form: powder for concentrate for solution for infusion
Active substance Dosage anidulafungina 100 mg -
It is used to treat adults with multiple myeloma, a type of bone marrow cancer, in patients whose cancer has recurred and no longer responds to previous treatments.
Dosage form: solution for injection
Active substance Dosage elranatamab 40 mg -
It is used in adults to treat complicated abdominal infections, hospital-acquired pneumonia (including ventilator-associated pneumonia), complicated urinary tract infections (such as pyelonephritis), and infections caused by Gram-negative bacteria that other antibiotics cannot eliminate.
Dosage form: powder for concentrate for solution for infusion
Active substance Dosage avibactam sodium 542 mg aztreonam 1500 mg -
What is Enbrel used for?": "It is used to treat severe psoriasis in children aged 6 years and older, juvenile idiopathic arthritis (polyarthritis or oligoarthritis in children over 2 years old and psoriatic arthritis in children over 12 years old), and enthesitis-related arthritis in children over 12 years old, when other treatments have not worked.", "When should this medication not be used?": "It should not be used if the child is allergic to etanercept or its components, if they suffer from or are at risk of a serious blood infection (sepsis), or if they have any type of active infection.", "How should Enbrel be administered?": "It is administered via a subcutaneous injection (under the skin). The dose and frequency depend on the child's weight and their disease, as directed by the doctor. The powder must be dissolved before use.", "What side effects can Enbrel cause?": "Very common side effects include infections (such as a cold or sinusitis), injection site reactions (pain, redness, or swelling), and headache. Allergic reactions, fever, rashes, or blood problems may also occur.", "What should I do if I notice an allergic reaction?": "If the child experiences difficulty breathing, swelling of the face, throat, hands, or feet, or a severe rash, do not administer any more Enbrel and contact your doctor immediately or go to the emergency room.", "Can I use other medications while taking this treatment?": "You must inform the doctor if the child is using other drugs, especially anakinra or abatacept, as these should not be used together with Enbrel. It is also important to report any diabetes medications.", "How should I store the medication?": "It must be stored in the refrigerator between 2 °C and 8 °C, do not freeze. Once out of the refrigerator, it can be kept at a maximum of 25 °C for a single period of up to 4 weeks.", "What happens if a dose is missed?": "You should inject it as soon as you remember, unless the next dose is scheduled for the following day. In that case, skip the missed dose and do not administer a double dose to make up for it."
Dosage form: powder and solvent for solution for injection
Active substance Dosage etanercept 10 mg -
It is used to treat rheumatoid arthritis (moderate or severe), psoriatic arthritis, severe axial spondyloarthritis (including ankylosing spondylitis), and moderate to severe psoriasis in adults. It is also prescribed in children and adolescents for certain types of juvenile idiopathic arthritis, enthesitis-related arthritis, and severe psoriasis.
Dosage form: powder and solvent for solution for injection
Active substance Dosage etanercept 25 mg -
It is used to treat rheumatoid arthritis (moderate or severe), psoriatic arthritis, axial spondyloarthritis (including ankylosing spondylitis), and psoriasis (moderate or severe) in adults. It is also prescribed in children and adolescents for certain types of juvenile idiopathic arthritis, enthesitis-related arthritis, and severe psoriasis.
Dosage form: solution for injection in pre-filled pen
Active substance Dosage etanercept 23.50 mg -
It is used in adults to treat moderate to severe rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis (including ankylosing spondylitis), and moderate to severe psoriasis. It is also prescribed in children and adolescents for certain types of juvenile idiopathic arthritis, enthesitis-related arthritis, and severe psoriasis.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage etanercept 25 mg -
It is used to treat moderate to severe rheumatoid arthritis, psoriatic arthritis, severe axial spondyloarthritis (including ankylosing spondylitis), and moderate to severe psoriasis in adults. It is also prescribed for children and adolescents with certain types of juvenile idiopathic arthritis, enthesitis-related arthritis, and severe psoriasis.
Dosage form: solution for injection in pre-filled pen
Active substance Dosage etanercept 50 mg -
It is used to treat rheumatoid arthritis (moderate or severe), psoriatic arthritis, severe axial spondyloarthritis (including ankylosing spondylitis), and moderate or severe psoriasis in adults. It is also prescribed in children and adolescents for juvenile idiopathic arthritis, enthesitis-related arthritis, and severe psoriasis, depending on age and the specific case.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage etanercept 50 mg -
It is used to prevent or reduce bleeding in patients 12 years of age or older weighing at least 35 kg who suffer from severe hemophilia A or severe hemophilia B (and who have not developed inhibitors to factors VIII or IX).
Dosage form: solution for injection in pre-filled pen
Active substance Dosage marstacimab 150 mg -
It is used to treat certain types of breast cancer that have spread beyond the original tumor or to other organs. It is administered alongside other hormonal treatments.
Dosage form: capsules, hard
Active substance Dosage palbociclib 100 mg -
It is used to treat certain types of breast cancer that have spread beyond the original tumor or to other organs. It is administered alongside other hormonal treatments.
Dosage form: capsules, hard
Active substance Dosage palbociclib 125 mg -
It is used to treat certain types of breast cancer that have spread beyond the original tumor or to other organs. It is administered alongside other hormonal treatments.
Dosage form: capsules, hard
Active substance Dosage palbociclib 75 mg -
It is used to treat advanced kidney cancer in adults, specifically when other medications have failed to slow the progression of the disease.
Dosage form: tablets, film-coated
Active substance Dosage axitinib 1,00 mg -
It is used to treat advanced kidney cancer (advanced renal cell carcinoma) in adults, when other medicines have not been successful in controlling the disease.
Dosage form: tablets, film-coated
Active substance Dosage axitinib 5,00 mg -
It is used to treat severe alopecia areata in adults and adolescents aged 12 years and older. This disease causes hair and body hair loss due to inflammation caused by the immune system itself.
Dosage form: capsules, hard
Active substance Dosage ritlecitinib tosylate 80,12 mg -
It is used to treat adults with a type of advanced lung cancer called non-small cell lung cancer (NSCLC), provided the disease is positive for the ALK gene alteration.
Dosage form: tablets, film-coated
Active substance Dosage lorlatinib 100 mg -
It is used to treat adults with a type of advanced lung cancer called non-small cell lung cancer (NSCLC), provided it is ALK-positive.
Dosage form: tablets, film-coated
Active substance Dosage lorlatinib 25 mg -
It is used to treat a type of blood cancer called acute myeloid leukemia (AML) in patients aged 15 years and older who have not received other treatments.
Dosage form: powder for concentrate and solution for infusion
Active substance Dosage gemtuzumab ozogamicine 5 mg -
It is used to treat children and adolescents aged 3 years and older who do not have enough growth hormone and are not growing at a normal rate.
Dosage form: solution for injection
Active substance Dosage somatrogon 24 mg -
It is used to treat children and adolescents aged 3 years and older who do not have enough growth hormone and are not growing at a normal rate.
Dosage form: solution for injection
Active substance Dosage somatrogon 60 mg -
It is a vaccine that helps protect against infections caused by the Neisseria meningitidis bacteria of types A, C, W-135, and Y, which can cause serious diseases such as meningitis or septicemia.
Dosage form: powder and solvent for solution for injection
Active substance Dosage meningococcal polysaccharide antigen group a 5 µg meningococcal group c polysaccharide antigen 5 µg meningococcal polysaccharide antigen group w-135 5 µg meningococcal polysaccharide antigen group y 5 µg -
It is a vaccine that helps protect against infections caused by Neisseria meningitidis bacteria of types A, C, W-135, and Y, which can cause serious diseases such as meningitis or septicemia.
Dosage form: powder and solvent for solution for injection
Active substance Dosage meningococcal polysaccharide antigen group a 5 µg meningococcal group c polysaccharide antigen 5 µg meningococcal polysaccharide antigen group w-135 5 µg meningococcal polysaccharide antigen group y 5 µg -
It is used to increase the number of white blood cells in various situations, such as after chemotherapy treatment or a bone marrow transplant, in cases of severe chronic neutropenia, or to help reduce the risk of infections in patients with advanced HIV infection.
Dosage form: solution for injection and for infusion
Active substance Dosage filgrastim 0,120 mg -
It is used to increase the number of white blood cells in various situations, such as after chemotherapy treatment or a bone marrow transplant to prevent infections, in cases of severe chronic neutropenia, or to help reduce the risk of infections in patients with advanced HIV infection.
Dosage form: solution for injection and infusion in pre-filled syringe
Active substance Dosage filgrastim 12 MILLONES UI -
It is used to increase the white blood cell count in people who have received chemotherapy or a bone marrow transplant, to help prevent infections. It is also prescribed in cases of severe chronic neutropenia and to reduce the risk of infections in patients with advanced HIV infection.
Dosage form: solution for injection and for infusion
Active substance Dosage filgrastim 0,300 mg -
It is used to increase the number of white blood cells in people who have received chemotherapy or a bone marrow transplant, to help prevent infections. It is also prescribed to treat severe chronic neutropenia, to assist patients with advanced HIV infection, or for stem cell collection before high-dose chemotherapy.
Dosage form: solution for injection and infusion in pre-filled syringe
Active substance Dosage filgrastim 30 MILLONES UI -
It is used to increase the number of white blood cells in cases of neutropenia following chemotherapy or bone marrow transplantation, to help prevent infections, to collect stem cells before high-dose chemotherapy, to treat severe chronic neutropenia, or to reduce the risk of infection in patients with advanced HIV infection.
Dosage form: solution for injection and for infusion
Active substance Dosage filgrastim 48 UI